Histogen Balance Sheet Health
Financial Health criteria checks 4/6
Histogen has a total shareholder equity of $4.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $5.8M and $1.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$4.57m |
| Equity | US$4.40m |
| Total liabilities | US$1.41m |
| Total assets | US$5.82m |
Recent financial health updates
Recent updates
Histogen stock down 8% after Q2 loss, on track for six-day losing streak
Aug 12Histogen announces pricing of $5M private placement
Jul 12We're A Little Worried About Histogen's (NASDAQ:HSTO) Cash Burn Rate
Dec 02
Histogen jumps 11% after Intracoastal Capital reports 5.6% stake
Jun 16Histogen enters $6.5M at-the-market direct offering
Jun 07Histogen under pressure on pricing $14M upsized public offering
Dec 31Histogen files IND application for regenerative human matrix
Dec 17Histogen soars after HST-001 data in male pattern baldness
Dec 01Financial Position Analysis
Short Term Liabilities: HSTO.Q's short term assets ($5.5M) exceed its short term liabilities ($1.3M).
Long Term Liabilities: HSTO.Q's short term assets ($5.5M) exceed its long term liabilities ($65.0K).
Debt to Equity History and Analysis
Debt Level: HSTO.Q is debt free.
Reducing Debt: HSTO.Q has no debt compared to 5 years ago when its debt to equity ratio was 61.3%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if HSTO.Q has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if HSTO.Q has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.